Hisamitsu Pharmaceutical Co., Inc.

TSE:4530 Stock Report

Market Cap: JP¥290.0b

Hisamitsu Pharmaceutical Management

Management criteria checks 1/4

Hisamitsu Pharmaceutical's CEO is Kazue Nakatomi, appointed in May 2015, has a tenure of 9.17 years. directly owns 0.33% of the company’s shares, worth ¥968.74M. The average tenure of the management team and the board of directors is 1 years and 10.2 years respectively.

Key information

Kazue Nakatomi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.2yrs
CEO ownership0.3%
Management average tenureless than a year
Board average tenure10.2yrs

Recent management updates

Recent updates

Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Jul 11
Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Jun 27
Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Jun 13
Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Apr 09
Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Mar 18
Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

CEO

Kazue Nakatomi (52 yo)

9.2yrs

Tenure

Mr. Kazuhide Nakatomi, also known as Kazue, serves as Chief Executive Officer since May 2019, President since May 2015 & Director since May 2007 at Hisamitsu Pharmaceutical Co. Inc. and served as its Chief...


Leadership Team

NamePositionTenureCompensationOwnership
Kazuhide Nakatomi
President9.2yrsno data0.33%
¥ 968.7m
Naruhito Higo
Executive VPless than a yearno datano data
Nobuo Tsutsumi
Exe Officer of Legal Affairs10.2yrsno data0.0068%
¥ 19.8m
Kosuke Sugiyama
Executive MD of Human Resourcesless than a yearno data0.018%
¥ 51.4m
Tetsuo Akiyama
Senior Managing Executive Officerless than a yearno datano data
Kyu Saito
MD, Executive Officerno datano data0.0095%
¥ 27.7m
Shinichi Murayama
Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Directorno datano data0.0082%
¥ 23.7m
Mitsutoshi Tsuruta
Senior Executive Officer & GM of Pharmaceutical Business Divisionno datano datano data
Masaya Okuno
Senior Executive Officer and GM of the Pharmaceuticals & Cosmetics Divisionno datano datano data
Koji Takiyama
Executive Officer3.2yrsno data0.0041%
¥ 11.9m
Katsuhiko Akiyama
Senior Executive Officer & GM of MN Business Promotion Office1.5yrsno datano data
Tomoya Suzuki
Executive Officer and GM of the Regional Mass Sales Dept of Pharmaceuticals & Cosmetics Divisionless than a yearno datano data

1.0yrs

Average Tenure

58.5yo

Average Age

Experienced Management: 4530's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Kazuhide Nakatomi
President17.2yrsno data0.33%
¥ 968.7m
Nobuo Tsutsumi
Exe Officer of Legal Affairs10.2yrsno data0.0068%
¥ 19.8m
Kosuke Sugiyama
Executive MD of Human Resources25.2yrsno data0.018%
¥ 51.4m
Kyu Saito
MD, Executive Officer11.2yrsno data0.0095%
¥ 27.7m
Shinichi Murayama
Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director10.2yrsno data0.0082%
¥ 23.7m
Koji Takiyama
Executive Officer3.2yrsno data0.0041%
¥ 11.9m
Munehiko Hirano
Standing Corporate Auditor18.2yrsno data0.0027%
¥ 7.9m
Tetsugo Matsuo
Part-time Outside Independent Director4.2yrsno data0.0014%
¥ 3.9m
Yuichiro Anzai
Part-time Outside Independent Director4.2yrsno datano data
Kentaro Watanabe
Part Time Outside Corporate Auditor1.2yrsno datano data
Tamako Watanabe
Part Time Outside Independent Director1.2yrsno datano data

10.2yrs

Average Tenure

57yo

Average Age

Experienced Board: 4530's board of directors are seasoned and experienced ( 10.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.